Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...
Päätekijät: | Eleonora M. Lad, Robert P. Finger, Robyn Guymer |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Adis, Springer Healthcare
2023-09-01
|
Sarja: | Ophthalmology and Therapy |
Aiheet: | |
Linkit: | https://doi.org/10.1007/s40123-023-00807-9 |
Samankaltaisia teoksia
-
Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
Tekijä: Treefa Shwani, et al.
Julkaistu: (2023-11-01) -
Age-Related Macular Degeneration: Classification and Pathogenesis
Tekijä: İmren Akkoyun
Julkaistu: (2014-12-01) -
Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
Tekijä: Reem H. ElSheikh, et al.
Julkaistu: (2022-11-01) -
Serum lipids in adults with late age-related macular degeneration: a case-control study
Tekijä: Richard D. Semba, et al.
Julkaistu: (2019-01-01) -
Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Tekijä: João Estarreja, et al.
Julkaistu: (2024-07-01)